Osteosarcoma

18 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Neoplasms, Sarcoma

Narrower: Sarcoma, Ewing 7

Treatments and conditions

Osteosarcoma
Treatment and conditionWhere it standsTrials
Abemaciclib + Irinotecan + Temozolomide for sarcoma, ewingPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Archive Sample Retrieval + Biospecimen Collection + pH Low Insertion Peptide-exatecan Conjugate CBX-12 + Radiologic Imaging Procedure for sarcoma, ewingTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Biopsy for osteosarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brachytherapy for osteosarcomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS) for sarcoma, ewingPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DOCETAXEL + Hydroxychloroquine + Gemcitabine for osteosarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Durvalumab + oleclumab for osteosarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Echocardiography + Biospecimen Collection + Computed Tomography + Multigated Acquisition Scan + Zanzalintinib for sarcoma, ewingPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HS-20093 for osteosarcomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irinotecan + Temozolomide for sarcoma, ewingPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Naxitamab for sarcoma, ewingPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Peptide vaccine IPX for sarcoma, ewingPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Proton beam radiation therapy + Surgical resection for osteosarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Proton beam radiation therapy + Surgical resection + PAZOPANIB + Doxorubicin + Ifosfamide for osteosarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Proton beam radiation therapy + Surgical resection + SELINEXOR + PAZOPANIB + Doxorubicin + Ifosfamide for osteosarcomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Regorafenib for osteosarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + Doxorubicin + CISPLATIN + Gefitinib + Disulfiram + SUNITINIB + Methotrexate for osteosarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + Gefitinib + Disulfiram + Ifosfamide + SUNITINIB for osteosarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.